Creabilis: <b>Creabilis</b>' CT327 Phase 2b Data Published In Acta Dermato-Venereologica, Strengthens Scientific Advisory Board

CANTERBURY, England, March 19, 2015 /PRNewswire/ --Prestigious peer-review journal accepts paper demonstrating a reduction of pruritus (itch) in psoriasis patients treated with its novel TrkA kinase inhibitor CT327Appointment of pre-eminent pruritus experts Professor Gil Yosipovitch as Chair and Professor Sonja Stnder to the Creabilis Scientific Advisory Board...